Skip to search formSkip to main contentSkip to account menu

Extended Release Oral Tablet

Known as: ER Tab, Extended Release Tablet, Extended Release Oral Tablet [Dose Form] 
A tablet designed to release active and/or inert ingredient(s) at a controlled, prolonged rate so as to reduce dosing frequency.
National Institutes of Health

Related topics

Related topics

50 relations
12 HR Carbamazepine 100 MG Extended Release Oral Tablet [Tegretol]12 HR Chlorpheniramine Maleate 12 MG Extended Release Oral Tablet [Chlor-Trimeton]12 HR Dextromethorphan Hydrobromide 60 MG / Guaifenesin 1200 MG Extended Release Oral Tablet12 HR Guaifenesin 600 MG Extended Release Oral Tablet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
FORMULATION AND EVALUATION OF CHLORPHENIRAMINE MALEATE EXTENDED RELEASE TABLETS BY USING DIRECT COMPRESSION TECHNIQUE
The objective of present investigation is to formulate and evaluate Chlorpheniramine maleate extended release tablets with… 
2015
2015
Pharmacokinetic and bioequivalence comparison between levetiracetam extended release tablets 750 mg : An open label , balanced , randomized-sequence , single-dose , two-period crossover study in…
This present bioequivalence study was designed to determine the pharmacokinetic, bioavailability and bioequivalence of… 
2013
2013
DESIGN AND OPTIMISATION OF EXTENDED RELEASE METOPROLOL SUCCINATE FORMULATION USING MELT GRANULATION TECHNIQUE
Metoprolol succinate (M.succinate), a BCS Class I drug is the most widely prescribed anti-hypertensive drug and is considered to… 
2013
2013
Formulation and evaluation of extended release tablets of salbutamol sulphate
The objective of this study was to formulate and evaluate Salbutamol sulphate matrix tablets, extended release dosage form, for… 
2013
2013
Application of Assumed IVIVC in Product Life Cycle Management: A CaseStudy of Trimetazidine Dihydrochloride Extended Release Tablet
The purpose of this study was to utilize IVIVC tool in the development of oral controlled release formulation of a BCS class I… 
2012
2012
Effect of cellulose and non-cellulose polymers on ciprofloxacin extended release tablets
Sustained release delivery systems have shown to be of better significance in release rate for drugs [1] . The present study was… 
2012
2012
Formulation and evaluation of atorvastatin loaded extended release tablets
The aim of our research work was to formulate and evaluate sustained release tablets of atorvastatin using the biomaterial as a… 
2008
2008
Factors Affecting the Formulation of Carbamazepine Extended Release Tablet
Carbamazepine is an anticonvulsant agent which acts on the central nervous system and used for the treatment of epilepsy… 
2002
2002
Eudragit NE 30 D Based Metformin / Gliclazide Extended Release Tablets : Formulation , Characterisation and in Vitro Release Studies Enose
glycemic agents belonging to biguanide group and secondgeneration sulphonyl urea respectively. Generally, they are individually… 
1997
1997
Biopharmaceutical aspects of extended release tablets based on the hydrophilic matrix principle
Biopharmaceutical aspects of extended release tablets based on the hydrophilic matrix principle